
Dr Ghasemali Divband
Expertise : Nuclear medicine
Educational Background:
- Encyclopedia of Nuclear Medicine, Mashhad University of Medical Sciences, 2017
Work Experience:
- Technical manager of the nuclear medicine department of Jam Hospital in Tehran from February 2020 to present.
- Head of the Radiopharmaceutical Therapy Unit in the CT/PET department of Khatam Al-Anbia Hospital in Tehran since March 2020.
- Collaboration with the CT/PET department of Khatam Alanbia Hospital in Tehran from March 2020 to present.
- Specialized K coefficient project: Behbahan University of Medical Sciences, technical director of the nuclear medicine department of Negar Parto Behbahan from July 2018 to October 2019.
Speaking engagements in continuing education programs:
A number of published English and Persian articles in reputable scientific-research journals:
- A number of published English and Persian articles in reputable scientific-research journals:
- Training on mammography and diagnostic nuclear medicine departments and principles of radiation protection Program ID 1
- One-day scientific conference on nuclear medicine and its applications, program ID 1
- The role of nuclear medicine in the diagnosis and treatment of prostate cancer, program ID 142487
- Treatment approaches in advanced prostate cancer and principles of treatment with Lutetium-PSMA radiopharmaceutical (07/24/2020) Program ID 157568
- Prostate Cancer - Diagnosis - Treatment Program ID 1
- Cervical lymph node metastases in thyroid cancers, program ID 1
- Webinar on Molecular Diagnostic and Therapeutic Updates in Head and Neck Cancers, Program ID 1
- The role of PET CT scans in common cancers - program ID 1
- The latest scientific advances in alpha radiopharmaceuticals, program ID 16
- Nuclear imaging and treatment with radiopharmaceuticals in pediatric cancers, program ID 188
- Annual Nuclear Medicine Conference 1402, Program ID 2066
- Annual Nuclear Medicine Conference 1402, Program ID 2066
- The 39th Iranian Congress of Radiology, program ID 2
- The role and application of nuclear technology in the healthcare system, program ID 2.
- Eighteenth International Breast Cancer Congress, Program ID 21
- HoseinSheibani H, MaryamTayefide, MaryamSaberi-Karimian, SusanDarroudi, MohsenMouhebati, Mohmoud RezaAzarpazhooh, GhasemaliDivband, Gordon A.Ferns, MohammadSafarian, MajidGhayour-Mobarhane. A comparison of body mass index and percent body fat as predictors of cardiovascular risk factors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018.
- Aghaee A, Darmani P, Divband G, et al. The effect of radioactive iodine therapy on urine sterilization in patients with differentiated thyroid cancer. Age. 2019;36:7.5.
- Iranian Society of Nuclear Medicine, Iranian Society of Medical Oncology/Hematology, and American Society of Clinical Oncology (ASCO)
Membership in